News Detail
New Delhi, 27 Feb 2025: Following its decision to make applications for clinical trial site addition and change of Principal Investigator available online, the Central Drugs Standard Control Organisation (CDSCO) has announced that similar applications for clinical trials of biolo......
View Details
Source : Pharmabiz
clinical trial site
Principal Investigator
CDSCO
regulatory submission procedure
Sugarm Portal
Global Clinical Trials
New Drugs
bioavailability
bioequivalence
rDNA
Clinical Trial Site Addition
PSUR
Post Approval Changes
PACs
National Single Window System
NSWS
Related News
- Karnataka notifies NDPS Rules, Essential Narcotic Drugs to be regulated under Central Rules (22-03-2025)
- One hundred teams participated in 'Operation Garuda', uncovering nearly 40 different types of drugs being sold without prescriptions (22-03-2025)
- List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)
- DCA seized four medicines for misleading 'Leucoderma', 'Tuberculosis' and 'Fever' treatment claims (21-03-2025)
- Skin specialists flag widespread quackery in Kerala (21-03-2025)
- SHRC orders criminal proceedings against fake doctor (21-03-2025)
- Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)
- CEPI and AstraZeneca to advance discovery into novel antibody (21-03-2025)
- FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)
- Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India (20-03-2025)